# Protective role of fatty acid oxidation against epithelial barrier dysfunction in allergic asthma

**Authors:** Muyun Wang, Yanan He, Haiyang Hu, Di Wu, Ximing Liao, Jing Gao, Shaoyong Gao, Huiming Yin, Kian Fan Chung, Qiang Li, Kun Wang, Wei Gao

PMC · DOI: 10.1080/13510002.2026.2613534 · Redox Report : Communications in Free Radical Research · 2026-01-19

## TL;DR

Fatty acid oxidation helps protect against asthma by maintaining lung cell barriers and reducing inflammation.

## Contribution

This study reveals that fatty acid oxidation protects against allergic asthma by preserving epithelial barrier function and reducing inflammation.

## Key findings

- FAO levels in lungs negatively correlate with inflammation and tissue injury in asthmatic mice.
- FAO regulates tight junction proteins and reduces epithelial barrier damage in bronchial cells.
- L-carnitine treatment alleviates asthma-related pathophysiology in both mice and cell models.

## Abstract

Fatty acid oxidation (FAO) is implicated in lung diseases, but its role in bronchial asthma is not fully understood. We investigated its effect on airway epithelial barrier integrity.

Using a house dust mite (HDM)-induced murine asthma model and HDM, IL-4, IL-13, or TNF-α stimulated human primary bronchial epithelial cells (BECs) and bronchial epithelial (Beas-2b) cells, we modulated FAO with L-carnitine (agonist) and Etomoxir (inhibitor). BECs and Beas-2b cells were infected with lentivirus-mediated CPT1A shRNA prior to stimulation. Barrier function, mitochondrial oxidative stress, inflammation, and metabolism were assessed.

FAO level in lungs negatively correlated with increased inflammation and tissue injury in HDM-induced asthmatic mice (all p < 0.05), while positively regulating tight junction protein expression. In BECs and Beas-2b cells, Etomoxir treatment and CPT1A knockdown exacerbated the impairment of FAO caused by various stimulants (all p < 0.05). Furthermore, FAO negatively regulated HDM/cytokine-induced epithelial barrier damage, hyperactive inflammatory response, and mitochondrial dysfunction in Beas-2b cells (all p < 0.05). In contrast, treatment with L-carnitine significantly alleviated these pathophysiological features in both in vivo and in vitro models.

FAO plays a protective role in the occurrence and development of asthma by maintaining airway epithelial cell homeostasis and barrier function.

## Linked entities

- **Genes:** CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374]
- **Chemicals:** L-carnitine (PubChem CID 288), Etomoxir (PubChem CID 9840324)
- **Diseases:** allergic asthma (MONDO:0004784)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374] {aka CPT I, CPT1, CPT1-L, CPTI-L, L-CPT1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}
- **Diseases:** asthma (MESH:D001249), mitochondrial dysfunction (MESH:D028361), tissue injury (MESH:D017695), inflammation (MESH:D007249), lung diseases (MESH:D008171), asthmatic (MESH:D013224)
- **Chemicals:** Etomoxir (MESH:C054207), L-carnitine (MESH:D002331), Fatty acid (MESH:D005227)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12821354/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12821354/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12821354/full.md

---
Source: https://tomesphere.com/paper/PMC12821354